Given the associations between faster post‐natal growth and greater obesity risk in childhood,9 it is essential to investigate the growth trajectories of metformin‐exposed children to determine whether they differ from those of insulin‐exposed children, according to growth period. This evidence concerns the gene INS and obesity disorder.